Your health

Research into the long-term effects of childhood cancer and its treatments is important. By investigating which symptoms can arise and in whom, we can intervene earlier and treat symptoms more effectively or even prevent them altogether. This ensures that you receive the care you need. Scientific research can also help to further improve current treatments. By learning what can happen later, doctors can ensure that future children not only get better, but also grow up with as few lasting problems as possible. In short, research into late effects ensures that children who have had cancer can lead as healthy and happy a life as possible — now and in the future.

Various researchers at the Princess Máxima Center are involved in research into late effects. Central to this is the collaboration between Prof. Leontien Kremer's research group (the Kremer group), the LATER clinic, and other stakeholders. We call this the M4C LATER, which stands for Máxima Comprehensive Childhood Cancer Center LATER. It combines healthcare and scientific research. Survivors from VOX, part of the Dutch Childhood Cancer Organization, are also closely involved and ensure that your voice is heard.

M4C LATER is involved in the development and harmonization of international guidelines. Summaries of scientific evidence (systematic reviews) are also produced. All of this involves international collaboration, for example with the European PanCare network and the International Late Effects of Childhood Cancer Guideline Harmonization Group (IGHG).

An example of a large Dutch study into late effects is the SKION LATER study, now known as the Dutch Childhood Cancer Survivor Study. You can find more information about this on the page below.